CSIMarket
 
Kymera Therapeutics Inc.  (KYMR)
Other Ticker:  
 
 


An eye-catching fall in Revenues at Kymera Therapeutics Inc. during the second quarter of 2022 earnings season

Kymera Therapeutics Inc. announced second quarter of 2022 operating shortfall of $-40.81 millions

Published 2022-08-13T00:09:18-04:00
Goran Soko / CSIMarket.com Contributer

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_CommonsFor the financial time-frame ending June 30 2022 Kymera Therapeutics Inc. increased a loss per share of $-0.78 per share compare to $-0.29 a year before and grew loss from $-0.71 per share from the previous financial reporting period.

Revenues faded by -38.434 % to $11.51 millions from $18.70 millions in the similar financial reporting period a year before and sequentially Revenues improved by 19.663 % from $9.62 millions.




For the financial time-frame ending June 30 2022 Kymera Therapeutics Inc. realized net loss of $-40.257 million, larger than $-13.075 million a year ago.


Kymera Therapeutics Inc. is expected to report next financial results on November 09, 2022.


    Recently Reported Results
Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Kintara Therapeutics Inc.

KTRA, decline in the business behavior all over financial span closing June 30 2022

As the April to June 30 2022 reporting season resumes, many entities have declared the results. Some of them, are many constituents of the Major Pharmaceutical Preparations sector. As well as, today, KTRA reported operating profit of $5.458 millions, for the financial period closing Jun 30 2022.


factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

Industrial production accelerates in July 2022

The output rate of the nation's factories, mines and utilities accelerated due to increase in production of cars by 6.1 %.

executive-2975480_960_720.jpg Nukkleus Inc.

Reasonable conduct at Nukkleus Inc. all along the fiscal third quarter of 2022

For the fiscal interval closing June 30 2022 Nukkleus Inc. Deficit has widen of $-0.01 per share compare to $0.00 a year ago and from $-0.01 per share from the previous reporting season.

Revenue grew by 6.415 % to $5.15 millions from $4.84 millions in the same reporting season a year ago and sequentially Revenues advanced by 1.241 % from $5.09 millions.


Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons Applied Genetic Technologies Corporation

For the fourth quarter of 2022 company increased a loss per share of $-0.36 per share compare to $-0.29 a year prior and grew loss from $-0.33 per share from the previous financial reporting period.

Revenues faded by -35 % to $0.33 millions from $0.50 millions in the similar financial reporting period a year prior and sequentially Revenues advanced from $0.00 millions.


Interior_pd Us Nuclear Corp.

Special results by Us Nuclear Corp. over the second quarter of 2022

For the second quarter of 2022 Us Nuclear Corp. lost money of $-0.01 per share compare to $-0.05 a year before and from $0.00 per share from the previous financial reporting period.

Revenues grew strongly by 65.24 % to $0.58 millions from $0.35 millions in the same financial reporting period a year before and sequentially Revenues surged by 71.588 % from $0.34 millions.


Warehouse_By Cayco_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Retail Inventories

U.S. industrial output on the rise again


workout_By_Nnu-12-22100541Tracy_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Productivity

Productivity declined in first-quarter of 2022


Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Personal Income and Spending

U.S. incomes outpace spending in the July 2022

Americans turned thriftier in the July 2022, spending less and saving more, according to fresh government data.

investment-2986344__340 Sanaby Health Acquisition Corp. I

The ascending company from the Blank Checks market the Sanaby Health Acquisition Corp. I published the fiscal time-frame ending fourth quarter of 2022, results

The shareholders haven't hoped for any changes at the business during the the April to June 30 2022 reporting season at the SANB. However, they monitor the company's operating deficit which has been at $-0.782574 millions, in the same period.


coins-948603__340 Simplicity Esports And Gaming Company

The Blank Checks company declared epic recent numbers, in the most recent fiscal period

IAMXU increased a deficit per share at $-5.25 per share in the most recent fiscal period, although its Revenues surged by 46.176 % to $0.92 millions from the same financial reporting period a year prior.


tax-468440__340 Biovie Inc.

The emerging entity from the Major Pharmaceutical Preparations market the Biovie Inc. reported the fourth quarter of 2022 earnings season, numbers

While the earnings cycle of fiscal April to June 30 2022 season continues, many companies have disclosed the numbers. Some of them, have been many businesses in the Major Pharmaceutical Preparations industry. And now, Biovie Inc. published operating loss of $-120.093011 millions, for the financial three months ending June 30 2022.


Silage_windrows_and_two_tractors_2 Cal Maine Foods Inc.

Again Positive Income at the Cal Maine Foods Inc. during the fiscal time-frame closing August 27 2022

For the fiscal time-frame closing August 27 2022 CALM earnings turned positive of $2.57 per share compare to $-0.37 a year prior and EPS advanced by 12.22 % from $2.29 per share from the preceding quarter.

Revenues grew strongly by 98.473 % to $658.34 millions from $331.70 millions in the similar quarter a year prior and sequentially Revenues advanced by 14.084 % from $577.07 millions.


Laptop_women_By_Petar_Milosevic_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Netsol Technologies Inc.

The Software & Programming company declared that Revenues were Soft, in the fiscal time-frame closing Jun 30 2022

For the fourth quarter of 2022 earnings season company posted a shortfall pers stock of $-0.19 per share compare to $0.17 a year prior and increased shortfall from $-0.02 per share from the prior reporting season.

Revenues decreased extensively by -11.865 % to $13.54 millions from $15.37 millions in the same reporting season a year prior and sequentially Revenue deteriorated by -8.544 % from $14.81 millions.


8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Aytu Biopharma Inc.

Aytu Biopharma Inc. declared strong double digit Revenues improvement, in the most recent fiscal period

For the most recent fiscal period AYTU decreased loss per share of $-0.49 per share compare to $-0.81 a year ago and EPS improved from $-1.79 per share from the previous reporting season.

Revenues inched up admirably by 16.887 % to $27.45 millions from $23.48 millions in the same reporting season a year ago and sequentially Revenues advanced by 13.426 % from $24.20 millions.




Other KYMR's Earnings Reports

Kymera Therapeutics reported third quarter 2022 earnings

Kymera Therapeutics reported second quarter 2021 earnings

Kymera Therapeutics reported first quarter 2021 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LIXT's Profile

Stock Price

LIXT's Financials

Business Description

Fundamentals

Charts & Quotes

LIXT's News

Suppliers

LIXT's Competitors

Customers & Markets

Economic Indicators

LIXT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071